Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B11-FC in Healthy Volunteers and Botulism Patients
NCT06580236Phase 2Not yet recruiting
- Start
- Aug 2024
- Primary completion
- Mar 2025
- Modality
- Monoclonal Antibodies, Fc-Fusion Proteins
01
Overview
A Phase 2 trial of B11-FC in botulism. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
B11-FC
03
Conditions
botulism
Beyond the preview
Go deeper on NCT06580236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06580236.